logo

For the Inventor, By the Inventor

Weymouth, MA, United States of America

Julian F Bond

This inventor holds 10 USPTO granted patents and 1 published patent application. Top assignees: Merck Patent Gmbh, Immulogic Pharmaceutical Corporation, Prodeg, LLC. Active years: 1996-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Julian F Bond. Retrieved from https://idiyas.com/inventor/julian-f-bond

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 70.0

Average Co-Inventor Count = 4.8

ph-index = 4

Forward Citations = 77(Granted Patents)


Company Filing History:

goldMedal3 out of 3,025 
 
Merck Patent Gmbh
 patents
silverMedal2 out of 36 
 
Immulogic Pharmaceutical Corporation
 patents
bronzeMedal2 out of 2 
 
Prodeg, LLC
 patents
4. 1 out of 5 
 
Ensemble Therapeutics Corporation
 patents
5. 2 out of 834,570 
Other
 patents

Years Active: 1996-2024

Loading Chart...
10 patents (USPTO):Explore Patents
1. 12168640 - USP9X inhibitors (2024-12-17),
2. 11691945 - USP9X inhibitors (2023-07-04),
3. 8540999 - Allergenic proteins and peptides from Japanese cedar pollen (2013-09-24),
4. 8338565 - Macrocyclic compounds for inhibition of tumor necrosis factor alpha (2012-12-25),
5. 7482008 - Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor (2009-01-27),
6. 7211408 - Recombitope peptides (2007-05-01),
7. 6982326 - Allergenic proteins and peptides from Japanese cedar pollen (2006-01-03),
8. 6120769 - Human T cell reactive feline protein (TRFP) isolated from house dust and (2000-09-19),
9. 6090386 - T cell peptides of the CRX JII allergen (2000-07-18),
10. 5547669 - Recombinant peptides comprising T cell epitopes of the cat allergen, Fel (1996-08-20),

Title: Innovations and Contributions of Julian F Bond

Introduction

Julian F Bond is a notable inventor based in Weymouth, MA (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 10 patents to his name, he has made remarkable strides in the development of compounds that target specific biological processes.

Latest Patents

Among his latest innovations are the USP9X inhibitors. These inventions relate to compounds that inhibit deubiquitinating enzymes (DUBs), particularly USP9X. The patents also encompass methods of inhibiting DUBs, including USP9X, and methods of treating various cancers. This work highlights his commitment to advancing medical science and improving treatment options for patients.

Career Highlights

Throughout his career, Julian has worked with prominent organizations, including Merck Patent GmbH. His experience in the pharmaceutical industry has equipped him with the knowledge and skills necessary to innovate and develop effective therapeutic solutions.

Collaborations

Julian has collaborated with esteemed colleagues such as Richard D Garman and Mei-chang Kuo. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Julian F Bond's contributions to the field of pharmaceuticals through his patents and collaborations underscore his role as a leading inventor. His work continues to impact the medical community positively, paving the way for future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…